Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
Year: 2009
Type: article
Study design: Clinical Trial
Source: Journal of Immunotherapy
Institutions: University of Tübingen, CureVac (Germany)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1966322307
